Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients

Health and Quality of Life Outcomes

Paul S Covington³  Douglas A Drossman¹  Donald L Patrick²  David A Andrae³ 

[1] Drossman Center for the Education and Practice of Biopsychosocial Care LLC, and UNC Center for Functional GI and Motility Disorders, Chapel Hill, NC, USA;Department of Health Services, University of Washington School of Public Health, Seattle, WA, USA;Furiex Pharmaceuticals, Inc., 3900 Paramount Parkway, Suite 150, Morrisville, NC 27560, USA

关键词: Eluxadoline;    Diarrhea;    Irritable Bowel Syndrome;    HRQOL;    Psychometrics;    Patient-reported Outcomes;    IBS-QOL;   

Others  :  821992
DOI  :  10.1186/1477-7525-11-208

 received in 2013-10-02, accepted in 2013-12-06,  发布年份 2013

【 摘 要 】

Background

Diarrhea-predominant irritable bowel syndrome (IBS-d) significantly diminishes the health-related quality of life (HRQOL) of patients. Psychological and social impacts are common with many IBS-d patients reporting comorbid depression, anxiety, decreased intimacy, and lost working days. The Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire is a 34-item instrument developed and validated for measurement of HRQOL in non-subtyped IBS patients. The current paper assesses this previously-validated instrument employing data collected from 754 patients who participated in a randomized clinical trial of a novel treatment, eluxadoline, for IBS-d.

Methods

Psychometric methods common to HRQOL research were employed to evaluate the IBS-QOL. Many of the historical analyses of the IBS-QOL validations were used. Other techniques that extended the original methods were applied where more appropriate for the current dataset. In IBS-d patients, we analyzed the items and substructure of the IBS-QOL via item reduction, factor structure, internal consistency, reproducibility, construct validity, and ability to detect change.

Results

This study supports the IBS-QOL as a psychometrically valid measure. Factor analyses suggested that IBS-specific QOL as measured by the IBS-QOL is a unidimensional construct. Construct validity was further buttressed by significant correlations between IBS-QOL total scores and related measures of IBS-d severity including the historically-relevant Irritable Bowel Syndrome Adequate Relief (IBS-AR) item and the FDA’s Clinical Responder definition. The IBS-QOL also showed a significant ability to detect change as evidenced by analysis of treatment effects. A minority of the items, unrelated to the IBS-d, performed less well by the standards set by the original authors.

Conclusions

We established that the IBS-QOL total score is a psychometrically valid measure of HRQOL in IBS-d patients enrolled in this study. Our analyses suggest that the IBS-QOL items demonstrate very good construct validity and ability to detect changes due to treatment effects. Furthermore, our analyses suggest that the IBS-QOL items measure a univariate construct and we believe further modeling of the IBS-QOL from an item response theory (IRT) approach under both non-treatment and treatment conditions would greatly further our understanding as item-based methods could be used to develop a short form.

【 授权许可】

   
2013 Andrae et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Lovell R, Ford A: Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012, 10:712-721.
• [2]Drossman D: The functional gastrointestinal disorders and the Rome III process. Gastroenterol 2006, 130:1377-1390.
• [3]Drossman D: Rome III The Functional GI Disorders. 3rd edition. Lawrence, KS: Allen Press, Inc; 2006.
• [4]Brandt L, Chey W, Foxx-Orenstein A: An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009, 104:1-35.
• [5]Dove L, Lembo A, Randall C, Fogel R, Andrae D, Davenport J, McIntyre G, Almenoff J, Covington P: Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study. Gastroenterology 2013, 145:329-338.
• [6]Patrick D, Drossman D, Frederick I, Dicesare J, Puder K: Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci 1998, 43:400-411.
• [7]Drossman D, Patrick D, Whitehead W, Toner B, Diamant N, Hu Y, Jia H, Bangdiwala S: Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol 2000, 95:999-1007.
• [8]Patrick D, Erickson P: Health Status and Health Policy: Allocating Resources to Health Care. New York, NY: Oxford University Press; 1993.
• [9]Thompson W, Creed F, Drossman D, Heaton K, Mazzacca G: Functional bowel disorders and functional abdominal pain. Gastroenterol Int 1992, 5:75-91.
• [10]Drossman D, Morris CB, Hu Y, Toner BB, Diamant N, Whitehead WE, Dalton CB, Leserman J, Patrick DL, Bangdiwala SI: Characterization of health related quality of life (HRQOL) for patients with functional bowel disorder (FBD) and its response to treatment. Am J Gastroenterol 2007, 102:1442-1453.
• [11]Francis C, Morris J, Whorwell P: The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997, 11:395-402.
• [12]Gorsuch R: Factor Analysis. Hillsdale, NJ: Lawrence Earlbaum Associates, Inc; 1983.
• [13]Holzinger K, Swineford F: The Bi-factor method. Psychometrika 1937, 2:41-54.
• [14]Swineford F: Some comparisons of the multiple-factor and the bi-factor methods of analysis. Psychometrika 1941, 6:375-382.
• [15]Kline R: Principles and Practice of Structural Equation Modeling. New York, NY: The Guilford Press; 1998.
• [16]Schreiber J, Nora A, Stage F, Barlow E, King J: Reporting structural equation modeling and confirmatory factor analysis results: a review. J Educ Res 2006, 99:323-338.
• [17]Bollen K, Curran P: Latent Curve Models: A Structural Equation Perspective. Hoboken, NJ: John Wiley & Sons; 2006.
• [18]Laenen A, Alonso A, Molenberghs G: A: measure for the reliability of a rating scale based on longitudinal clinical trial data. Psychometrika 2007, 72:443-448.
• [19]Laenen A, Alonso A, Molenberghs G, Vangeneugden T: Reliability of a longitudinal sequence of scale ratings. Psychometrika 2009, 74:49-64.
• [20]Spiegel B, Camilleri M, Bolus R, Andresen V, Chey WD, Fehnel S, Mangel A, Talley NJ, Whitehead WE: Psychometric evaluation of endpoints in IBS randomized controlled trials: a Rome foundation working group report. Gastroenterology 2009, 137:1944-1953.
• [21]Food and Drug Administration: Guidance for industry irritable bowel syndrome–clinical evaluation of drugs for treatment: final guidance. 2012. http://www.fda.gov/downloads/Drugs/Guidances/UCM205269.pdf webcite
• [22]Das Gupta S: Point biserial correlation and its generalization. Psychometrika 1960, 25:393-408.
• [23]Brogden H: A new coefficient: application to biserial correlation and to estimation of selective efficiency. Psychometrika 1949, 14:169-182.
• [24]Cohen J: A power primer. Psychol Bull 1992, 112:155-159.
• [25]R Core Team R: A language and environment for statistical computing. 2013. http://www.R-project.org/ webcite] R Foundation for Statistical Computing
• [26]Rizopoulos D: Ltm: An R package for latent variable modeling and item response theory analysis. J Stat Softw 2006, 17:1-25.
• [27]SAS: Version 9.3 SAS system for windows. SAS Institute; http://www.sas.com/ webcite
• [28]Cronbach L: Coefficient alpha and the internal structure of tests. Psychometrika 1951, 6:297-334.
• [29]Sijtsma K: On the use, the misuse, and the very limited usefulness of Cronbach’s alpha. Psychometrika 2009, 74:107-120.
• [30]Green S, Yang Y: Commentary on coefficient alpha: a cautionary tale. Psychometrika 2009, 74:121-137.
• [31]Revelle W, Zinbarg R: Coefficients alpha, beta, omega, and the GLB: comments on Sijtsma. Psychometrika 2009, 74:145-154.
• [32]Bentler P: Alpha, dimension-free, and model-based internal consistency reliability. Psychometrika 2009, 74:137-143.
• [33]Green S, Yang Y: Reliability of summed item scores using structural equation modeling: an alternative to coeficient alpha. Psychometrika 2009, 74:155-167.
• [34]Hambleton R, Swaminathan H: Item Response Theory: Principles and Applications. Boston, MA: Kluwer Nijhoff Publishing; 1985.